17-alpha-hydroxyprogesterone has been researched along with Menopause in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (50.00) | 18.7374 |
| 1990's | 8 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ROSSI, PG | 1 |
| Dowsett, M; Harris, AL; Jeffcoate, SL; Smith, IE | 1 |
| Butkus, A; Coghlan, JP; Denton, DA; Saines, D; Scoggins, BA; Whitworth, JA | 1 |
| Acampora, MG; Dell'Acqua, S; Lucisano, A; Maniccia, E; Montemurro, A; Russo, N | 1 |
| Ahern, J; Dowsett, M; Iveson, TJ; Smith, IE; Smithers, DA; Trunet, PF | 1 |
| Bucciante, G; Maggino, T; Pirrone, F; Velluti, F | 1 |
| Deal, SR; Gavaler, JS; Van Thiel, DH | 1 |
| Pieleszek, A | 1 |
| Demers, LM; Garber, JE; Hanagan, J; Harvey, H; Henderson, IC; Lipton, A; Lynch, J; Mulagha, M; Navari, RM; Santen, RJ | 1 |
| Cantwell, BM; Dowsett, M; Harris, AL; Mehta, A | 1 |
| Jensen, J | 1 |
| Bennet, A; Caron, P; Carton, M; Gorguet, B; Martel, P; Roche, H | 1 |
| Bonfrer, JM; Bruning, PF; de Jong-Bakker, M; Hart, AA; Moolenaar, AJ; Nooijen, WJ; van der Linden, E | 1 |
| Bezrukova, OD; Breusenko, VG; Shalina, RI; Solomatina, AA | 1 |
| Barbieri, RL; Friedman, AJ; Ravnikar, VA | 1 |
| Cantwell, BM; Dowsett, M; Harris, AL | 1 |
1 review(s) available for 17-alpha-hydroxyprogesterone and Menopause
| Article | Year |
|---|---|
Effects of sex steroids on serum lipids and lipoproteins.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Coronary Disease; Drug Administration Routes; Estrogen Replacement Therapy; Female; Humans; Hydroxyprogesterones; Lipids; Lipoproteins; Lipoproteins, LDL; Menopause; Progesterone Congeners; Risk Factors | 1991 |
3 trial(s) available for 17-alpha-hydroxyprogesterone and Menopause
| Article | Year |
|---|---|
Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal women.
Topics: 17-alpha-Hydroxyprogesterone; Administration, Oral; Aged; Aldosterone; Androstenedione; Aromatase Inhibitors; Dose-Response Relationship, Drug; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Hydroxyprogesterones; Letrozole; Luteinizing Hormone; Male; Menopause; Middle Aged; Nitriles; Random Allocation; Testosterone; Thyrotropin; Time Factors; Triazoles | 1993 |
[The effect of carbon disulphide on menopause, concentration of monoamines, gonadotropins, estrogens and androgens in women].
Topics: 17-alpha-Hydroxyprogesterone; Abortion, Spontaneous; Adult; Carbon Disulfide; Chemical Industry; Dopamine; Environmental Monitoring; Epidemiological Monitoring; Epinephrine; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Incidence; Menopause; Menstrual Cycle; Menstruation Disturbances; Middle Aged; Norepinephrine; Occupational Exposure; Poland; Pregnancy; Progesterone; Retrospective Studies; Serotonin | 1997 |
Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer.
Topics: 17-alpha-Hydroxyprogesterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Drug Evaluation; Estradiol; Estrone; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Menopause; Middle Aged; Receptors, Estrogen | 1989 |
12 other study(ies) available for 17-alpha-hydroxyprogesterone and Menopause
| Article | Year |
|---|---|
[Effect of 17-alpha-hydroxyprogesterone acetate on urinary gonadotropins].
Topics: 17-alpha-Hydroxyprogesterone; Acetates; Castration; Climacteric; Female; Gonadotropins; Humans; Male; Menopause; Orchiectomy; Progesterone | 1958 |
Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Cosyntropin; Dehydroepiandrosterone; Drug Administration Schedule; Drug Therapy, Combination; Estrone; Female; Hormones; Humans; Hydrocortisone; Hydroxyprogesterones; Menopause; Middle Aged | 1983 |
Plasma 4-pregnene-17 alpha, 20 alpha-diol-3-one (17 alpha, 20 alpha-dihydroxyprogesterone) and 17 alpha-hydroxyprogesterone in man.
Topics: 17-alpha-Hydroxyprogesterone; Addison Disease; Adolescent; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Circadian Rhythm; Contraceptives, Oral; Dexamethasone; Diet, Sodium-Restricted; Female; Humans; Hydroxyprogesterones; Male; Menopause; Menstruation | 1983 |
Ovarian and peripheral plasma levels of progestogens, androgens and oestrogens in post-menopausal women.
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Estradiol; Estrogens; Estrone; Female; Humans; Hydroxyprogesterones; Menopause; Middle Aged; Ovary; Progesterone; Testosterone | 1984 |
The role of the endocrine factors and obesity in hormone-dependent gynecological neoplasias.
Topics: 17-alpha-Hydroxyprogesterone; Adipose Tissue; Aged; Androgens; Body Mass Index; Body Weight; Breast Neoplasms; Endometrial Neoplasms; Estradiol; Female; Hormones; Humans; Hydroxyprogesterones; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Obesity; Pyrones; Regression Analysis; Risk Factors; Sex Hormone-Binding Globulin | 1993 |
Surgical risk in alcoholic cirrhotic postmenopausal women: prognostic value of levels of hormones.
Topics: 17-alpha-Hydroxyprogesterone; Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Hepatic Encephalopathy; Humans; Hydroxyprogesterones; Hyperprolactinemia; Liver Cirrhosis, Alcoholic; Liver Transplantation; Luteinizing Hormone; Menopause; Middle Aged; Pituitary Hormones; Prognosis; Prolactin; Risk Factors; Survival Rate; Testosterone | 1993 |
Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitor.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aldosterone; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrone; Fadrozole; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Imidazoles; Kinetics; Menopause; Nitriles | 1991 |
Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Estrone; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Menopause; Middle Aged; Thyroxine; Triiodothyronine | 1991 |
Mammary ovarian metastases with stroma cell hyperplasia and postmenopausal virilization.
Topics: 17-alpha-Hydroxyprogesterone; Breast Neoplasms; Carcinoma; Female; Humans; Hydroxyprogesterones; Hyperplasia; Menopause; Middle Aged; Muscle, Smooth; Ovarian Neoplasms; Ovary; Receptors, Estradiol; Receptors, Progesterone; Testosterone; Virilism | 1990 |
[Rheologic and coagulable properties of the blood in patients with hyperplastic processes in the endometrium in the postmenopausal period during hormonal therapy].
Topics: 17-alpha-Hydroxyprogesterone; Aged; Blood Coagulation; Blood Viscosity; Endometrial Hyperplasia; Female; Humans; Hydroxyprogesterones; Menopause; Middle Aged | 1986 |
Serum steroid hormone profiles in postmenopausal smokers and nonsmokers.
Topics: 17-alpha-Hydroxyprogesterone; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estradiol; Estrone; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Menopause; Middle Aged; Progesterone; Smoking; Steroids; Testosterone | 1987 |
High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer.
Topics: 17-alpha-Hydroxyprogesterone; Aged; Aged, 80 and over; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Ketoconazole; Menopause; Middle Aged; Sex Hormone-Binding Globulin; Testosterone | 1988 |